Abstract

Ultraviolet radiation (UVR) damages the dermis and fibroblasts; and increases melanoma incidence. Fibroblasts and their matrix contribute to cancer, so we studied how UVR modifies dermal fibroblast function, the extracellular matrix (ECM) and melanoma invasion. We confirmed UVR-damaged fibroblasts persistently upregulate collagen-cleaving matrix metalloprotein-1 (MMP1) expression, reducing local collagen (COL1A1), and COL1A1 degradation by MMP1 decreased melanoma invasion. Conversely, inhibiting ECM degradation and MMP1 expression restored melanoma invasion. Primary cutaneous melanomas of aged humans show more cancer cells invade as single cells at the invasive front of melanomas expressing and depositing more collagen, and collagen and single melanoma cell invasion are robust predictors of poor melanoma-specific survival. Thus, primary melanomas arising over collagen-degraded skin are less invasive, and reduced invasion improves survival. However, melanoma-associated fibroblasts can restore invasion by increasing collagen synthesis. Finally, high COL1A1 gene expression is a biomarker of poor outcome across a range of primary cancers.

Ultraviolet radiation (UVR) increases melanoma incidence. Here, the authors report that UVR-damaged dermal fibroblasts upregulate MMP1 to degrade collagen which inhibits melanoma invasion and that aged primary melanomas in skin with degraded collagen have a better prognosis, while new collagen synthesis restores invasion and leads to death.

Details

Title
Ultraviolet light-induced collagen degradation inhibits melanoma invasion
Author
Budden, Timothy 1 ; Gaudy-Marqueste Caroline 2 ; Porter, Andrew 3   VIAFID ORCID Logo  ; Kay, Emily 4 ; Gurung Shilpa 1 ; Earnshaw, Charles H 1   VIAFID ORCID Logo  ; Roeck Katharina 1 ; Craig, Sarah 1   VIAFID ORCID Logo  ; Traves Víctor 5 ; Krutmann Jean 6   VIAFID ORCID Logo  ; Muller, Patricia 7 ; Motta, Luisa 8 ; Zanivan Sara 4   VIAFID ORCID Logo  ; Malliri Angeliki 3   VIAFID ORCID Logo  ; Furney, Simon J 9   VIAFID ORCID Logo  ; Nagore Eduardo 10   VIAFID ORCID Logo  ; Amaya, Virós 1   VIAFID ORCID Logo 

 The University of Manchester, Skin Cancer and Ageing Lab, Cancer Research UK Manchester Institute, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407) 
 Aix-Marseille University, Department of Dermatology and Skin Cancers, Marseille, France (GRID:grid.5399.6) (ISNI:0000 0001 2176 4817) 
 The University of Manchester, Alderley Park, Cell Signalling Group, Cancer Research UK Manchester Institute, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407) 
 University of Glasgow, Institute of Cancer Sciences, Glasgow, UK (GRID:grid.8756.c) (ISNI:0000 0001 2193 314X); CRUK Beatson Institute, Glasgow, UK (GRID:grid.8756.c) 
 Institut Valencià Oncologia, Department of Dermatology, Valencia, Spain (GRID:grid.5379.8) 
 IUF – Leibniz Research Institute of Environmental Medicine, Düsseldorf, Germany (GRID:grid.435557.5) (ISNI:0000 0004 0518 6318); Heinrich-Heine-University, Medical Faculty, Düsseldorf, Germany (GRID:grid.411327.2) (ISNI:0000 0001 2176 9917) 
 The University of Manchester, Tumour Suppressors Lab, Cancer Research UK Manchester Institute, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407) 
 The University of Manchester, Department of Histopathology, Salford Royal NHS Foundation Trust, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407) 
 Royal College of Surgeons in, Genomic Oncology Research Group, Department of Physiology and Medical Physics, Dublin, Ireland (GRID:grid.4912.e) (ISNI:0000 0004 0488 7120); Royal College of Surgeons in Ireland Dublin, Centre for Systems Medicine, Dublin, Ireland (GRID:grid.4912.e) (ISNI:0000 0004 0488 7120) 
10  Institut Valencià Oncologia, Department of Dermatology, Valencia, Spain (GRID:grid.4912.e) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2525891137
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.